Mesoblast Ltd- Spon Adr (MESO) 13F Filing Data & Analysis (Q2 2026)

MESO ranks #5277 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

MESO is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

73 institutions disclose a position in MESO, but none treat it as a major bet — even Penbrook Management LLC, its most concentrated holder, allocates just 0.8% of its own portfolio to it.

UBS Group AG has added to its MESO position for two straight quarters, increasing it by $1.4M to reach $2.7M today.

BlackRock has trimmed its MESO position for two straight quarters, cutting it by $3.2M while still holding $9.0M.

MESO is up 4.8% today, and institutions have been net buyers of $22.3M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

MESO reported a net loss of $81.9M over the trailing twelve months.

• Not yet profitable — net loss of $81.9M over the trailing twelve months
• Revenue declined 24.4% year over year
• Net income improved year over year, from -$91.3M to -$81.9M
• Operating cash flow was negative, using $43.8M in cash
• Current ratio of 2.43x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.36x equity — within a conventional range